Fierce Healthcare March 16, 2023
By Robert King

Insurers are not doing enough to help providers participate in confirmatory trials of drugs that hit the market through accelerated approval, FDA Commissioner Robert Califf, M.D., said. (pcess609/iStock/Getty Images Plus)

WASHINGTON, D.C.—Insurers must do more to help providers participate in clinical trials that can confirm the effectiveness of drugs granted accelerated approval, Food and Drug Administration Commissioner Robert Califf, M.D., told a room full of payer executives Thursday.

Califf spoke about how to improve the accelerated approval process during a session at the AHIP 2023 Medicare, Medicaid, Duals & Commercial Markets Forum in Washington, D.C. The remarks come as the FDA has new powers granted by Congress to get drug companies to finish trials for drugs after they...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Biotechnology, Clinical Trials, FDA, Govt Agencies, Insurance, Pharma, Pharma / Biotech, Provider, Trends
Use AI to regulate AI, Google executive says
The Current State Of 521 FDA-Approved, AI-Based Medical Devices
Elon Musk’s Neuralink Wants To Put Chips In Our Brains — How It Works And Who Else Is Doing It
Over-the-Counter Hearing Aids — Using Regulatory Policy to Improve Public Health
FDA Updates Cybersecurity Guidance

Share This Article